BMY Insider Trading Activity and SEC Form 4 Filings
Trump's trades in BMY
From his financial disclosures
$178K+
9 purchases
$33K+
5 sales
Sale
Jun 23, 2026
Reported 60d later
$1K - $15K
Purchase
Jun 12, 2026
Reported 71d later
$15K - $50K
Purchase
May 18, 2026
Reported 44d later
$1K - $15K
Sale
May 18, 2026
Reported 44d later
$1K - $15K
Purchase
May 15, 2026
Reported 47d later
$15K - $50K
Sale
May 11, 2026
Reported 51d later
$15K - $50K
Many orders in these accounts are placed by the account manager. See all 14 trades
BMY insider trading summary
Over the past 12 months, insiders at Bristol Myers Squibb Co (BMY) reported 4 sales worth $2.1M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.1M.
Latest BMY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Julia A Haller | Director | Sell | $241K (3,800 @ $63.31) |
| Aug 25, 2026 | Phil M Holzer | SVP and Controller | Sell | $34K (500 @ $67.50) |
| Apr 1, 2026 | David V Elkins | EVP, Chief Financial Officer | Sell | $1.6M (25,519 @ $61.60) |
| Apr 1, 2026 | David V Elkins | EVP, Chief Financial Officer | Sell | $278K (4,481 @ $62.05) |
| Sep 2, 2025 | David V Elkins | EVP, Chief Financial Officer | Sell | $2.7M (56,000 @ $47.33) |
| Aug 2, 2025 | Bartie Wendy Short | EVP, Corporate Affairs | Sell | $17K (378 @ $44.23) |
| May 9, 2025 | Benjamin Hickey | President, RayzeBio Org. | Sell | $4K (97.391 @ $38.01) |
| Apr 25, 2025 | Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Buy | $202K (4,250 @ $47.58) |
| Feb 20, 2025 | Christopher S. Boerner | Chief Executive Officer | Buy | $110K (2,000 @ $55.05) |
| Feb 14, 2025 | Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Buy | $100K (1,823.486 @ $54.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.